Europe Respiratory Care Devices Market

According to Renub Research, the Europe Respiratory Care Devices Market is projected to grow from US$ 6.8 Billion in 2024 to US$ 12.97 Billion by 2033, exhibiting a CAGR of 7.45% from 2025 to 2033.
Explore Full Report


Rising Respiratory Health Burden Drives European Market for Care Devices

The demand for respiratory care devices across Europe is surging due to a growing prevalence of respiratory disorders like chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and acute lower respiratory tract infections. According to Renub Research, this increasing disease burden is being exacerbated by factors such as aging populations, urban air pollution, tobacco consumption, and sedentary lifestyles.

In response, the Europe Respiratory Care Devices Market is anticipated to nearly double its valuation from US$ 6.8 billion in 2024 to US$ 12.97 billion by 2033, growing at a CAGR of 7.45% during the forecast period. As Europe intensifies its healthcare investments post-COVID-19, the market for ventilators, nebulizers, oxygen concentrators, and diagnostic respiratory devices is experiencing unprecedented growth.


Technological Innovation is Transforming Respiratory Care Delivery

Digital health integration, wearable monitoring, and home-based care devices are significantly improving respiratory disease management in the region. The adoption of smart inhalers, portable oxygen concentrators, and AI-enabled ventilators has expanded access to advanced respiratory care solutions, especially among home care users and elderly patients.

Key European manufacturers are introducing compact, efficient, and user-friendly devices tailored to patient needs. These include:

  • Wearable respiratory monitors for real-time health tracking.

  • Bluetooth-enabled CPAP machines for sleep apnea patients.

  • Smart nebulizers integrated with mobile applications for therapy management.

This wave of innovation is enabling remote patient monitoring, early disease detection, and personalized treatment planning—ultimately reducing hospitalization rates and enhancing quality of life.


Home Healthcare Segment Gains Traction Amid Demographic Shifts

With Europe’s population aging rapidly, there is a growing preference for home-based respiratory care, especially among those suffering from chronic illnesses. Home care reduces healthcare costs, improves convenience, and minimizes infection risks—a crucial advantage highlighted during the COVID-19 pandemic.

Renub Research data indicates that homecare settings are expected to witness the fastest growth among all end-use segments. Countries such as Germany, France, Italy, and the United Kingdom are leading this shift through government-funded healthcare programs and reimbursement support.

Moreover, home-use respiratory care devices such as portable ventilators, oxygen concentrators, and handheld spirometers are increasingly preferred over hospital-based alternatives.


Country-Level Insights: Germany, France, and the UK Lead Market Growth

Germany

Germany represents the largest share of the European respiratory care devices market, supported by its robust healthcare infrastructure and growing elderly population. High incidence of COPD and government initiatives on air quality are fueling the demand for therapeutic and monitoring devices.

France

France is seeing rising adoption of portable respiratory devices, particularly in homecare and elderly care facilities. The French healthcare system is also encouraging the use of telemonitoring and smart devices to ensure continuous care and cost efficiency.

United Kingdom

With a focus on digital health and remote monitoring, the UK market is growing significantly. Initiatives like the NHS Long Term Plan emphasize early detection of chronic conditions like asthma and COPD, supporting adoption of diagnostic and therapeutic equipment.


Market Segmentation Highlights

By Product Type

  • Therapeutic Devices: Ventilators, CPAP, BiPAP, nebulizers

  • Monitoring Devices: Pulse oximeters, capnographs

  • Diagnostic Devices: Spirometers, peak flow meters

  • Consumables & Accessories: Masks, circuits, cannulas

By End-User

  • Hospitals

  • Home Healthcare

  • Ambulatory Surgical Centers

  • Others (e.g., Clinics and Emergency Services)

The therapeutic devices segment holds the largest market share, owing to increased usage in the treatment of asthma, COPD, and obstructive sleep apnea. However, monitoring and diagnostic devices are expected to grow steadily due to the rising trend in disease prevention and early diagnosis.


Leading Companies Shaping the Europe Respiratory Care Devices Market

Top players in the Europe respiratory care devices market are focusing on innovation, strategic partnerships, and regulatory approvals to gain a competitive edge. These include:

  • Philips Healthcare

  • ResMed

  • Medtronic

  • GE Healthcare

  • Fisher & Paykel Healthcare

  • Drägerwerk AG

  • Masimo Corporation

  • Smiths Medical

  • Vyaire Medical

  • Air Liquide

These companies are increasingly investing in AI integration, wireless connectivity, and wearable formats to modernize traditional respiratory equipment.


Regulatory Framework and Reimbursement Policies Fuel Market Expansion

The European Union’s favorable regulatory environment and reimbursement mechanisms are playing a vital role in the uptake of advanced respiratory care technologies. CE-marking procedures, Medical Device Regulation (MDR), and national health insurance support are ensuring safety compliance, market transparency, and affordability of respiratory care products.

Public awareness campaigns and governmental policies addressing air quality, smoking cessation, and respiratory health screening further complement industry growth.


Challenges: Pricing Pressures and Device Maintenance

Despite growth prospects, certain challenges hinder full-scale adoption. These include:

  • High initial cost of advanced respiratory devices.

  • Complex device maintenance and servicing.

  • Reimbursement limitations in some countries.

  • Lack of skilled personnel for managing complex devices.

However, rising healthcare digitization, economies of scale, and local manufacturing are gradually mitigating these hurdles.


Conclusion: Europe Set to Breathe Easier with Advancing Respiratory Care Ecosystem

The Europe Respiratory Care Devices Market is on a high-growth trajectory, supported by demographic trends, chronic disease prevalence, and technological breakthroughs. As countries aim to make healthcare more accessible, efficient, and patient-centered, respiratory care devices will be central to managing both acute and chronic respiratory conditions.

With the market projected to reach US$ 12.97 Billion by 2033, stakeholders across healthcare and medical device sectors should leverage this opportunity to innovate, collaborate, and expand in one of the most promising segments of the European healthcare landscape.

👉 Access the full report here:
https://www.renub.com/europe-respiratory-care-devices-market-p.php

New Publish Report:


About the Company

Renub Research is a Market Research and Consulting Company with more than 15 years of experience, especially in international Business-to-Business Research, Surveys, and Consulting. We provide a wide range of business research solutions that help companies make better business decisions. We partner with clients across all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

Our wide clientele includes key players in Healthcare, Travel & Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemicals, Logistics & Automotive, Consumer Goods & Retail, Building & Construction, and Agriculture. Our core team comprises experienced professionals with graduate, postgraduate, and Ph.D. qualifications in Finance, Marketing, Human Resources, Bio-Technology, Medicine, Information Technology, Environmental Science, and more.


Media Contact
Company Name: Renub Research
Contact Person: Rajat Gupta, Marketing Manager
Phone No: +91-120-421-9822 (IND) | +1-478-202-3244 (USA)
Email: rajat@renub.com

Leave a Reply

Your email address will not be published. Required fields are marked *